The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
COMy 2016 | Which techniques to use to assess disease response in multiple myeloma
Carlos Fernandez de Larrea, MD, PhD from the Hospital Clínic de Barcelona, Barcelona, Spain discusses which techniques can be used to establish disease response in multiple myeloma (MM). For the detection of minimal residual disease (MRD), the most established technique is flow cytometry. In terms of imaging, clear criteria for the evaulation of PET/CT are required. Dr de Larrea further discussses the importance of standardizing the various techniques. Recorded at the 2016 World Congress on Controversies in Multiple Myeloma (COMy) in Paris, France.
